Company / Capital Expenditures
KIORA PHARMACEUTICALS INC Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$6.3K
FY2025
5-year range
$0 / $20.1K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 7 years, ranging from $0 in FY2024 to $36,999 in FY2018.
Based on SEC 10-K filings.
$6,256 in FY2025.
Declined from $20,077 to $6,256 over the past 4 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak capital expenditures was recorded in FY2018.
- Lowest capital expenditures in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.3K | - |
| FY2024 | $0 | -100.0% |
| FY2021 | $20.1K | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $20.0K | -45.9% |
| FY2018 | $37.0K | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026